Lucid Diagnostics Announces Peer-Reviewed Publication of Positive Data from National Cancer Institute-Sponsored, Prospective, Multicenter Clinical Validation Study of EsoGuardĀ® Esophageal Precancer Testing
Stock Information for PAVmed Inc.
Loading
Please wait while we load your information from QuoteMedia.